RLAY Chart
- 52-Week Range: $15.27 - $37.99
- Market Capitalization: $1.98B
- Short Percentage: 0%
- Target Price: $44.86
- Shares Outstanding: 108.66M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
RLAY released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Relay Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate HighlightsGlobeNewsWire | February 24th
- Relay Therapeutics to Announce Fourth Quarter and Full Year 2021 Financial Results and Corporate HighlightsGlobeNewsWire | February 17th
- Relay Therapeutics to Participate in Two Upcoming Investor ConferencesGlobeNewsWire | February 2nd
- Relay Therapeutics to Present at 40th Annual J.P. Morgan Healthcare ConferenceGlobeNewsWire | January 3rd
- Relay Therapeutics Reports Third Quarter 2021 Financial Results and Recent Corporate HighlightsGlobeNewsWire | November 10th
- Relay Therapeutics to Announce Third Quarter 2021 Financial Results and Recent Corporate HighlightsGlobeNewsWire | November 4th
- Relay Therapeutics Announces Pricing of Public Offering of Common StockGlobeNewsWire | October 12th
- Relay Therapeutics Announces Proposed Public Offering of Common StockGlobeNewsWire | October 11th
Company Info
Website: https://www.relaytx.com
Address: 399 Binney Street, Cambridge, MA, United States, 02139
Sector: Healthcare
Industry: Biotechnology
Full time employees: 245
Address: 399 Binney Street, Cambridge, MA, United States, 02139
Sector: Healthcare
Industry: Biotechnology
Full time employees: 245
$RLAY Who’s still buying calls?
$RLAY Nope
$RLAY Nope
$RLAY has just been halted from trading due to volatility.
$RLAY has just been halted from trading due to volatility.
$RLAY has just been halted from trading.
$RLAY Free money indeed??
$RLAY let's gooooooo
$RLAY it begins tomorrow